Cargando…
Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154648/ https://www.ncbi.nlm.nih.gov/pubmed/36884283 http://dx.doi.org/10.2337/dc23-0083 |
| _version_ | 1785036172145197056 |
|---|---|
| author | Martínez-Montoro, José Ignacio Picón-César, María José Simón-Frapolli, Víctor José Pinzón-Martín, José Luis García-Alemán, Jorge Durán-Martínez, María Tinahones, Francisco J. |
| author_facet | Martínez-Montoro, José Ignacio Picón-César, María José Simón-Frapolli, Víctor José Pinzón-Martín, José Luis García-Alemán, Jorge Durán-Martínez, María Tinahones, Francisco J. |
| author_sort | Martínez-Montoro, José Ignacio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10154648 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101546482023-05-04 Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study Martínez-Montoro, José Ignacio Picón-César, María José Simón-Frapolli, Víctor José Pinzón-Martín, José Luis García-Alemán, Jorge Durán-Martínez, María Tinahones, Francisco J. Diabetes Care e-Letters – Observations American Diabetes Association 2023-05 2023-03-08 /pmc/articles/PMC10154648/ /pubmed/36884283 http://dx.doi.org/10.2337/dc23-0083 Text en © 2023 by the American Diabetes Association https://www.diabetesjournals.org/journals/pages/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license. |
| spellingShingle | e-Letters – Observations Martínez-Montoro, José Ignacio Picón-César, María José Simón-Frapolli, Víctor José Pinzón-Martín, José Luis García-Alemán, Jorge Durán-Martínez, María Tinahones, Francisco J. Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study |
| title | Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study |
| title_full | Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study |
| title_fullStr | Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study |
| title_full_unstemmed | Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study |
| title_short | Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study |
| title_sort | evaluation of the clinical impact of dapagliflozin discontinuation as adjunctive therapy for patients with type 1 diabetes after indication withdrawal: a two-center retrospective study |
| topic | e-Letters – Observations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154648/ https://www.ncbi.nlm.nih.gov/pubmed/36884283 http://dx.doi.org/10.2337/dc23-0083 |
| work_keys_str_mv | AT martinezmontorojoseignacio evaluationoftheclinicalimpactofdapagliflozindiscontinuationasadjunctivetherapyforpatientswithtype1diabetesafterindicationwithdrawalatwocenterretrospectivestudy AT piconcesarmariajose evaluationoftheclinicalimpactofdapagliflozindiscontinuationasadjunctivetherapyforpatientswithtype1diabetesafterindicationwithdrawalatwocenterretrospectivestudy AT simonfrapollivictorjose evaluationoftheclinicalimpactofdapagliflozindiscontinuationasadjunctivetherapyforpatientswithtype1diabetesafterindicationwithdrawalatwocenterretrospectivestudy AT pinzonmartinjoseluis evaluationoftheclinicalimpactofdapagliflozindiscontinuationasadjunctivetherapyforpatientswithtype1diabetesafterindicationwithdrawalatwocenterretrospectivestudy AT garciaalemanjorge evaluationoftheclinicalimpactofdapagliflozindiscontinuationasadjunctivetherapyforpatientswithtype1diabetesafterindicationwithdrawalatwocenterretrospectivestudy AT duranmartinezmaria evaluationoftheclinicalimpactofdapagliflozindiscontinuationasadjunctivetherapyforpatientswithtype1diabetesafterindicationwithdrawalatwocenterretrospectivestudy AT tinahonesfranciscoj evaluationoftheclinicalimpactofdapagliflozindiscontinuationasadjunctivetherapyforpatientswithtype1diabetesafterindicationwithdrawalatwocenterretrospectivestudy |